HERPES VIRUS (HHV 3) - VARICELLA ZOSTER - ANVISA Registration 10322250067

Access comprehensive regulatory information for HERPES VIRUS (HHV 3) - VARICELLA ZOSTER in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10322250067 and manufactured by QIAGEN GMBH. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until May 30, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, DIASORIN ITALIA S.P.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10322250067
2 Related Devices
Registration Details
ANVISA Registration Number: 10322250067
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10322250067

25351913145201634

01334250000120

Company Information

QIAGEN GMBH
Germany
PT: ALEMANHA

Dates and Status

May 30, 2016

30/05/2026

09/18/2025 19:00:01

Registration Details

10322250067

25351913145201634

01334250000120

Company Information

Dates and Status

May 30, 2016

30/05/2026

09/18/2025 19:00:01